Biodel Inc. Awarded National Institutes of Health (NIH) Grant to Develop Glucagon Formulations for Use in Artificial Pancreas

Published: Sep 24, 2012

DANBURY, Conn., Sept. 24, 2012 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel a grant for the development of novel and stable glucagon formulations for use in an artificial pancreas, also known as a closed loop pump system.

Back to news